Literature DB >> 32238355

Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.

Jeanne Lenzer1.   

Abstract

Entities:  

Year:  2020        PMID： 32238355     DOI： 10.1136/bmj.m1335

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  40 in total

1.  Pandemic-Related Submissions: The Challenge of Discerning Signal Amidst Noise.

Authors:  Lewis J Kaplan; Thomas P Bleck; Timothy G Buchman; R Phillip Dellinger; Clifford S Deutschman; John C Marshall; David M Maslove; Henry Masur; Margaret M Parker; Donald S Prough; Aarti Sarwal; Jonathan E Sevransky; Jean-Louis Vincent; Jerry J Zimmerman
Journal:  Crit Care Med       Date:  2020-06-11       Impact factor: 7.598

2.  Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.

Authors:  Leon Peto; Peter Horby; Martin Landray
Journal:  Adv Biol Regul       Date:  2022-07-19

3.  Electrophysiological and Proarrhythmic Effects of Hydroxychloroquine Challenge in Guinea-Pig Hearts.

Authors:  Gongxin Wang; Chieh-Ju Lu; Andrew W Trafford; Xiaohui Tian; Hannali M Flores; Piotr Maj; Kevin Zhang; Yanhong Niu; Luxi Wang; Yimei Du; Xinying Ji; Yanfang Xu; Lin Wu; Dan Li; Neil Herring; David Paterson; Christopher L-H Huang; Henggui Zhang; Ming Lei; Guoliang Hao
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-30

4.  Prescribing COVID-19 treatments: what we should never forget.

Authors:  S Tunesi; A Bourgarit
Journal:  J Infect       Date:  2020-05-13       Impact factor: 6.072

5.  Quantity does not equal quality: Scientific principles cannot be sacrificed.

Authors:  Piotr Rzymski; Michał Nowicki; Gerard E Mullin; Ajith Abraham; Eduardo Rodríguez-Román; Moritz B Petzold; Antonia Bendau; Kamal Kant Sahu; Amber Ather; Anne-Frédérique Naviaux; Pascal Janne; Maximilien Gourdin; Joris R Delanghe; Hans D Ochs; James E Talmadge; Manish Garg; Michael R Hamblin; Nima Rezaei
Journal:  Int Immunopharmacol       Date:  2020-06-22       Impact factor: 4.932

6.  Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

Authors:  Janna Krueger; Francois Santinon; Alexandra Kazanova; Mark E Issa; Bruno Larrivee; Richard Kremer; Catalin Milhalcioiu; Christopher E Rudd
Journal:  PLoS One       Date:  2021-06-28       Impact factor: 3.240

7.  Hydroxychloroquine shortage.

Authors:  J Patel; P Coulthard
Journal:  Br Dent J       Date:  2020-06       Impact factor: 2.727

Review 8.  Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.

Authors:  Serena Colafrancesco; Rossana Scrivo; Cristiana Barbati; Fabrizio Conti; Roberta Priori
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

9.  Pandemic-Related Submissions: The Challenge of Discerning Signal Amidst Noise.

Authors:  Thomas P Bleck; Timothy G Buchman; R Phillip Dellinger; Clifford S Deutschman; John C Marshall; David M Maslove; Henry Masur; Margaret M Parker; Donald S Prough; Aarti Sarwal; Jonathan E Sevransky; Jean-Louis Vincent; Jerry J Zimmerman
Journal:  Crit Care Med       Date:  2020-08       Impact factor: 9.296

Review 10.  Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics.

Authors:  Ramesh Kandimalla; Albin John; Chandrika Abburi; Jayalakshmi Vallamkondu; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2020-07-15       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.